BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36200503)

  • 1. [The treatment of ovarian cancer. Recommendation of the Hungarian Society of Gynaecologic Oncologists].
    Novák Z; Bagaméri A; Máté S; Vereczkey I; Tóth E; Tóth I; Papp S; Krasznai Z
    Magy Onkol; 2022 Oct; 66(3):223-238. PubMed ID: 36200503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
    Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
    Colombo N; Sessa C; Bois AD; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Int J Gynecol Cancer; 2019 May; ():. PubMed ID: 31048403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
    Ledermann JA; Matias-Guiu X; Amant F; Concin N; Davidson B; Fotopoulou C; González-Martin A; Gourley C; Leary A; Lorusso D; Banerjee S; Chiva L; Cibula D; Colombo N; Croce S; Eriksson AG; Falandry C; Fischerova D; Harter P; Joly F; Lazaro C; Lok C; Mahner S; Marmé F; Marth C; McCluggage WG; McNeish IA; Morice P; Nicum S; Oaknin A; Pérez-Fidalgo JA; Pignata S; Ramirez PT; Ray-Coquard I; Romero I; Scambia G; Sehouli J; Shapira-Frommer R; Sundar S; Tan DSP; Taskiran C; van Driel WJ; Vergote I; Planchamp F; Sessa C; Fagotti A
    Ann Oncol; 2024 Mar; 35(3):248-266. PubMed ID: 38307807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best original research presented at the 24
    Kacperczyk-Bartnik J; Bizzarri N; Zwimpfer TA; El Hajj H; Angeles MA; Tóth R; Theofanakis C; Bilir E; Gasimli K; Strojna AN; Nikolova T; Ayhan A; Lorusso D; Chiva L
    Int J Gynecol Cancer; 2024 Apr; 34(4):610-618. PubMed ID: 38088184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM).
    Gadducci A; Aletti GD; Landoni F; Lazzari R; Mangili G; Olivas P; Pignata S; Salutari V; Sartori E; Scambia G; Zannoni GF; Sabbatini R; Lorusso D
    Tumori; 2021 Apr; 107(2):100-109. PubMed ID: 33106117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of qualitative research on gynaecologic oncology guidelines.
    How JA; Abitbol J; Lau S; Gotlieb WH; Abenhaim HA
    J Obstet Gynaecol Can; 2015 Feb; 37(2):138-144. PubMed ID: 25767946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Radiother Oncol; 2015 Dec; 117(3):559-81. PubMed ID: 26683800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
    Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
    Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
    Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
    Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No. 230-Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses.
    Le T; Giede C
    J Obstet Gynaecol Can; 2018 Mar; 40(3):e223-e229. PubMed ID: 29525047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial evaluation and referral guidelines for management of pelvic/ovarian masses.
    Le T; Giede C; Salem S; Lefebvre G; Rosen B; Bentley J; Kupets R; Power P; Renaud MC; Bryson P; Davis DB; Lau S; Lotocki R; Senikas V; Morin L; Bly S; Butt K; Cargill YM; Denis N; Gagnon R; Hietala-Coyle MA; Lim KI; Ouellet A; Raciot MH;
    J Obstet Gynaecol Can; 2009 Jul; 31(7):668-80. PubMed ID: 19761648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
    Jacobson M; Bernardini M; Sobel ML; Kim RH; McCuaig J; Allen L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1497-1510. PubMed ID: 30473125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO).
    Bizzarri N; Pletnev A; Razumova Z; Zalewski K; Theofanakis C; Selcuk I; Nikolova T; Lanner M; Gómez-Hidalgo NR; Kacperczyk-Bartnik J; Querleu D; Cibula D; Verheijen RHM; Fagotti A
    Int J Gynecol Cancer; 2022 Apr; 32(4):494-501. PubMed ID: 34992130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
    Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
    Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Training for next-generation gynaecologic surgical & radiation oncologists - opportunities & challenges.
    Ram TS; Thomas V; Sathyamurthy A; Ramireddy JK; John NO; Thomas A; Peedicayil A
    Indian J Med Res; 2021 Aug; 154(2):338-345. PubMed ID: 35295005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
    Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
    J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of advanced ovarian cancer in Spain: an expert Delphi consensus.
    Redondo A; Oaknin A; Rubio MJ; Barretina-Ginesta MP; de Juan A; Manso L; Romero I; Martin-Lorente C; Poveda A; Gonzalez-Martin A
    J Ovarian Res; 2021 May; 14(1):72. PubMed ID: 34039386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.